A multicenter, observational, prospective-retrospective data collection study of patients with lung cancer.
start of the project: 05/2026
Primární cíle
- Collection of epidemiological and clinical data on patients with lung cancer in the Czech Republic.
Sekundární cíle
- Assessment of treatment quality – evaluation of overall survival (OS) and progression-free survival (PFS).
- Analysis of response to individual treatment modalities in real-world clinical practice (real-world data).
Odborná garance
Czech Pneumological and Phthisiological Society of the Czech Medical Association of J.E. Purkyně
Garantem registru je doc. MUDr. Martin Svatoň, Ph.D.
Projektový management
Institute of Biostatistics and Analyses, Ltd., a spin-off company of Masaryk University, ensures management and other service activities for this project.
Mgr. Magda Matusíková, Project ManagerIng. Petr Brabec, Ph.D., Managing Director
- Anaesthesiology, intensive care medicine
- Cardiology, angiology
- Diabetology, dietetics
- Educational projects
- Emergency medicine, toxicology
- Endocrinology, metabolism
- Gastroenterology, hepatology
- Haematology, haematological oncology
- Immunology, allergology
- Medical genetics
- Nephrology
- Neurology, neurosurgery
- Nursing care
- Obstetrics, gynaecology
- Oncology, radiotherapy
- Ophthalmology
- Paediatrics, neonatology
- Pathology, laboratory medicine
- Pulmonary medicine
- Rheumatology, physiotherapy
- Screening programmes
- Surgery, traumatology, orthopaedics
- Urology